Safety and long-term effect of the probiotic FK-23 in patients with hepatitis C virus infection

Bioscience of Microbiota, Food and Health

Volumn 35, Issue 3, 2016, Pages 123-128

  Oo, Khin May ^a   Lwin, Aye Aye ^a   Kyaw, Yi Yi ^a   Tun, Win Maw ^a   Fukada, Kazutake ^b   Goshima, Akiko ^b   Shimada, Takashi ^b,c   Okada, Shigeru ^d  

^a Department of Medical Research ^*  (Myanmar)

^b Central Research Laboratories   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^d OKAYAMA UNIVERSITY   (Japan)

Author keywords

Alanine aminotransferase (ALT); Aspartate transaminase (AST); Enterococcus faecalis FK 23; Probiotic

Indexed keywords

EID: 85026867911     PISSN: 21866953     EISSN: 21863342     Source Type: Journal    
DOI: 10.12938/bmfh.2015-024     Document Type: Article

References (25)

1. Kyi PK, Win KM. 1995. Viral hepatitis in Myanmar. DMR Bull 9: 1-31
2. Kyi PK, Win KM, Aye M, Htwe YY, Oo KM, Aung T, Oo SS. 1998. Prevalence of hepatitis B and C infection in hepatocellular carcinoma cases in Myanmar. Myanmar Health Sci Res J 10: 1-5
3. Win KM. 2000. Clinical aspect of hepatitis C infection. Proceeding of Seminar on Control of Hepatitis C in Myanmar: 6-10
4. Gupta S, Kanodia AK. 2002. Biological response modifiers in cancer therapy. Natl Med J India 15: 202-207
5. Huber CH, Wölfel T. 2004. Immunotherapy of cancer: from vision to standard clinical practice. J Cancer Res Clin Oncol 130: 367-374
6. Fuller R. 1989. Probiotics in man and animals. J Appl Bacteriol 66: 365-378
7. Salminen S, von Wright A, Morelli L, Marteau P, Brassart D, de Vos WM, Fondén R, Saxelin M, Collins K, Mogensen G, Birkeland SE, Mattila-Sandholm T. 1998. Demonstration of safety of probiotics-a review. Int J Food Microbiol 44: 93-106
8. Majamaa H, Isolauri E, Saxelin M, Vesikari T. 1995. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr 20: 333-338
9. Fedorak RN, Madsen KL. 2004. Probiotics and prebiotics in gastrointestinal disorders. Curr Opin Gastroenterol 20: 146-155
10. Sakamoto I, Igarashi M, Kimura K, Takagi A, Miwa T, Koga Y. 2001. Suppressive effect of Lactobaccilus gasseri OLL 2716 (LG 21) on Helicobacter pylori infection in humans. J Antimicrob Chemother 47: 709-710
11. Kato I, Endo K, Yokokura T. 1994. Effects of oral administration of Lactocbaccilus casei on anti-tumor responses induced by tumor resection in mice. Int J Immunopharmacol 16: 29-36
12. Jauhiainen T, Vapaatalo H, Poussa T, Kyrönpalo S, Rasmussen M, Korpela R. 2005. Lactobacillus helveticus fermented milk lowers blood pressure in hypertensive subjects in 24 hour ambulatory blood pressure measurement. Am J Hypertens 18: 1600-1605
13. Ooi LG, Liong MT. 2010. Cholesterol-lowering effects of probiotics and prebiotics: a review of in vivo and in vitro findings. Int J Mol Sci 11: 2499-2522
14. Shimada T, Cheng L, Enomoto T, Yang X, Miyoshi A, Shirakawa T. 2004. Lysed Enterococcus faecalis FK-23 oral administration reveals inverse association between tuberculin response and clinical manifestations in perennial allergitis rhinitis: a pilot study. J Investig Allergol Clin Immunol 14: 187-192
15. Myo-Khin, San-San-Oo, Oo KM, Shimono K, Koide N, Okada S. 2010. Prevalence and factors associated with hepatitis C virus infection among Myanmar blood donors. Acta Med Okayama 64: 317-321
16. Khin M, Swe TN. 2003. Contributions by the Japan International Cooperation Agency to hepatitis C control and research in Myanmar. DMR Bull 17: 1-17
17. Gratz SW, Mykkanen H, El-Nezami HS, Nezami E. 2010 Probiotics and gut health: a special focus on liver diseases. World J Gastroenterol 16: 403-410
18. Nicole CL. 2010. Could probiotics help those with hepatitis C. Retrieved from http:www.hepatitiscentral. com/mHarchives/2010/12/
19. Imani Fooladi AA, Mahmoodzadeh Hosseini H, Nourani MR, Khani S, Alavian SM. 2013. Probiotic as a novel treatment strategy against liver disease. Hepat Mon 13: e7521
20. Maki N, Nohmi T, Shimada T, Yajin S, Yoda S, Ikeda H, Enomoto T. 2004. Efficacy of heat-treated Enterococcus faecalis FK-23 preparations on serum aminotransferase levels in patients with chronic type C hepatitis. Journal of the Japan Red Cross Society, Wakayama Medical Center 22: 19-24
21. Kondoh M, Shimada T, Fukada K, Morita M, Katada K, Higashimura Y, Mizushima K, Okamori M, Naito Y, Yoshikawa T. 2014. Beneficial effects of heat-treated Enterococcus faecalis FK-23 on high-fat diet-induced hepatic steatosis in mice. Br J Nutr 112: 868-875
22. Zafrani ES. 2004. Non-alcoholic fatty liver disease: an emerging pathological spectrum. Virchows Arch 444: 3-12
23. Son G, Kremer M, Hines IN. 2010. Contribution of gut bacteria to liver pathobiology. Gastroenterol Res Pract 2010: 453563
24. Chan CC, Hwang SJ, Lee FY, Wang SS, Chang FY, Li CP, Chu CJ, Lu RH, Lee SD. 1997. Prognostic value of plasma endotoxin levels in patients with cirrhosis. Scand J Gastroenterol 32: 942-946
25. Shimada T, Cheng L, Shi HB, Hayashi A, Motonaga C, Tang J, Enomoto K, Enomoto T. 2007. Effect of lysed Enterococcus faecalis FK-23 on allergeninduced immune responses and intestinal microflora in antibiotic-treated weaning mice. J Investig Allergol Clin Immunol 17: 70-76